MAC
Macerich Company (The)
Latest News for MAC
Cantor Fitzgerald analyst Joshua Schimmer maintained a Buy rating on Diamedica Therapeutics yesterday and set a price target of $25.00. The company......
Marechale Capital ( ($GB:MAC) ) has provided an update. Marechale Capital reported a weaker first half for the six months to 31 October 2025, with ......
In a report released yesterday, James Fletcher CFA from Berenberg Bank maintained a Buy rating on Macfarlane, with a price target of p90.00. Accord......
Analysts have been eager to weigh in on the Real Estate sector with new ratings on Curbline Properties Corp. (CURB – Research Report) and Macerich ......
Diamedica Therapeutics ( ($DMAC) ) has issued an announcement. On December 19, 2025, DiaMedica Therapeutics Inc. sold 1,501,000 common shares to a ......
News data is sourced from MarketXLS API and updated regularly.
Showing 5 of 5 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MAC | $18.18 | -1.2% | 973.00K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |